Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Tim, Amos"'
Autor:
Siân Lowri Griffiths, Samuel P. Leighton, Pavan Kumar Mallikarjun, Georgina Blake, Linda Everard, Peter B. Jones, David Fowler, Joanne Hodgekins, Tim Amos, Nick Freemantle, Vimal Sharma, Max Marshall, Paul McCrone, Swaran P. Singh, Max Birchwood, Rachel Upthegrove
Publikováno v:
Translational Psychiatry, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Early psychosis is characterised by heterogeneity in illness trajectories, where outcomes remain poor for many. Understanding psychosis symptoms and their relation to illness outcomes, from a novel network perspective, may help to delineate
Externí odkaz:
https://doaj.org/article/3979a36d43ae4fd682f76bfb016fe7e9
Autor:
Imogen Stokes, Siân Lowri Griffiths, Rowena Jones, Linda Everard, Peter B. Jones, David Fowler, Joanne Hodgekins, Tim Amos, Nick Freemantle, Vimal Sharma, Max Marshall, Swaran P. Singh, Max Birchwood, Rachel Upthegrove
Publikováno v:
BJPsych Open, Vol 6 (2020)
BackgroundTreatment resistance causes significant burden in psychosis. Clozapine is the only evidence-based pharmacologic intervention available for people with treatment-resistant schizophrenia; current guidelines recommend commencement after two un
Externí odkaz:
https://doaj.org/article/4e169cfece2d4d9094e6a3b67e458d07
Autor:
Siân Lowri Griffiths, Tumelo Bogatsu, Mia Longhi, Emily Butler, Beel Alexander, Mrunal Bandawar, Linda Everard, Peter B. Jones, David Fowler, Joanne Hodgekins, Tim Amos, Nick Freemantle, Paul McCrone, Swaran P. Singh, Max Birchwood, Rachel Upthegrove
Acknowledgements: M.B. and S.P.S are part funded by the National Institute for Health Research through the Applied Research Collaboration West Midlands (ARC-WM). P.B.J. is part funded by the NIHR ARC East of England. The views expressed in this publi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed6a32d37e830924d2a2703a0d3452a2
Autor:
Vimal Sharma, David Fowler, Pavan Mallikarjun, Paul McCrone, Max Marshall, Rachel Upthegrove, Linda Everard, Swaran P. Singh, Georgina Blake, Samuel P Leighton, Max Birchwood, Peter B. Jones, Tim Amos, Siân Lowri Griffiths, Nick Freemantle, Joanne Hodgekins
Publikováno v:
Translational Psychiatry, Vol 11, Iss 1, Pp 1-8 (2021)
Translational Psychiatry
Translational Psychiatry
Funder: Department of Health (DH); doi: https://doi.org/10.13039/501100000276
Early psychosis is characterised by heterogeneity in illness trajectories, where outcomes remain poor for many. Understanding psychosis symptoms and their relation to
Early psychosis is characterised by heterogeneity in illness trajectories, where outcomes remain poor for many. Understanding psychosis symptoms and their relation to
Autor:
Thomas RE Barnes, Verity C Leeson, Carol Paton, Louise Marston, Linda Davies, William Whittaker, David Osborn, Raj Kumar, Patrick Keown, Rameez Zafar, Khalid Iqbal, Vineet Singh, Pavel Fridrich, Zachary Fitzgerald, Hemant Bagalkote, Peter M Haddad, Mariwan Husni, Tim Amos
Publikováno v:
Health Technology Assessment, Vol 21, Iss 49 (2017)
Background: When treatment-refractory schizophrenia shows an insufficient response to a trial of clozapine, clinicians commonly add a second antipsychotic, despite the lack of robust evidence to justify this practice. Objectives: The main objectives
Externí odkaz:
https://doaj.org/article/7d0f857d5d3a4123b885763809d0af80
Autor:
Tim Amos, Max Birchwood, Nick Freemantle, Danielle Hett, Swaran P. Singh, David Fowler, Vimal Sharma, Peter G. Jones, Paul McCrone, Linda Everard, Sonia Johnson, Steven Marwaha, Joanne Hodgekins
Publikováno v:
Acta psychiatrica ScandinavicaREFERENCES. 144(4)
Objective\ud The extant literature is inconsistent over whether manic symptoms in first‐episode psychosis (FEP) impact on its development and trajectory. This study addressed the following: (1) Does Duration of Untreated Illness (DUI) and Duration
Autor:
Joanne Hodgekins, Rowena Jones, Max Birchwood, Swaran P. Singh, Nick Freemantle, Peter B. Jones, Max Marshall, Rachel Upthegrove, Vimal Sharma, Tim Amos, Siân Lowri Griffiths, Imogen Stokes, David Fowler, Linda Everard
Publikováno v:
BJPsych Open
Background Treatment resistance causes significant burden in psychosis. Clozapine is the only evidence-based pharmacologic intervention available for people with treatment-resistant schizophrenia; current guidelines recommend commencement after two u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3079fc06525fe85635a8baf9a7434185
https://ueaeprints.uea.ac.uk/id/eprint/77125/
https://ueaeprints.uea.ac.uk/id/eprint/77125/
Autor:
Imran B Chaudhry, Tim Amos, Robin M. Murray, Vimal Sharma, Helen L. Fisher, Max Birchwood, Shôn Lewis, Nusrat Husain, Iain Buchan, Richard Drake, Peter B. Jones, Linda Everard, David Fowler, Max Marshall, Til Wykes, Nick Freemantle, Swaran P. Singh, Barbara Tomenson, Chloe D Green
Publikováno v:
Drake, R, Husain, N, Lewis, S, Tomenson, B & Chaudhry, I 2020, ' Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study ', The Lancet Psychiatry, vol. 7, no. 7, pp. 602-610 . https://doi.org/10.1016/S2215-0366(20)30147-4
LANCET PSYCHIATRY
Drake, R J, Husain, N, Marshall, M, Lewis, S W, Tomenson, B, Chaudhry, I B, Everard, L, Singh, S, Freemantle, N, Fowler, D, Jones, P B, Amos, T, Sharma, V, Green, C D, Fisher, H, Murray, R M, Wykes, T, Buchan, I & Birchwood, M 2020, ' Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes : a longitudinal analysis and modelling study ', The Lancet Psychiatry, vol. 7, no. 7, pp. 602-610 . https://doi.org/10.1016/S2215-0366(20)30147-4
The Lancet. Psychiatry
LANCET PSYCHIATRY
Drake, R J, Husain, N, Marshall, M, Lewis, S W, Tomenson, B, Chaudhry, I B, Everard, L, Singh, S, Freemantle, N, Fowler, D, Jones, P B, Amos, T, Sharma, V, Green, C D, Fisher, H, Murray, R M, Wykes, T, Buchan, I & Birchwood, M 2020, ' Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes : a longitudinal analysis and modelling study ', The Lancet Psychiatry, vol. 7, no. 7, pp. 602-610 . https://doi.org/10.1016/S2215-0366(20)30147-4
The Lancet. Psychiatry
Background: Delayed treatment for first episodes of psychosis predicts worse outcomes. We hypothesised that delaying treatment makes all symptoms more refractory, with harm worsening first quickly, then more slowly. We also hypothesised that although
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28197d552c0facc379d9874546adc55e
https://www.research.manchester.ac.uk/portal/en/publications/effect-of-delaying-treatment-of-firstepisode-psychosis-on-symptoms-and-social-outcomes-a-longitudinal-analysis-and-modelling-study(36298575-ee94-45a7-ad85-b60c040d90b8).html
https://www.research.manchester.ac.uk/portal/en/publications/effect-of-delaying-treatment-of-firstepisode-psychosis-on-symptoms-and-social-outcomes-a-longitudinal-analysis-and-modelling-study(36298575-ee94-45a7-ad85-b60c040d90b8).html
Autor:
Nick Chamberlain-Kent, Helen L. Fisher, John Joyce, Nikola Rahaman, Peter B. Jones, Max Birchwood, Kate Tilling, Robert G. Carroll, Jo Lawrence, Sonia Johnson, Paul Moran, Barnaby Major, David Fowler, Sarah A Sullivan, Tim J Peters, Max Marshall, Tim Amos
Publikováno v:
Sullivan, S, Carroll, R, Peters, TJ, Amos, T, Jones, P B, Marshall, M, Birchwood, M, Fowler, D, Johnson, S, Fisher, H L, Major, B, Rahaman, N, Joyce, J, Chamberlain-Kent, N, Lawrence, J, Moran, P & Tilling, K 2019, ' Duration of untreated psychosis and clinical outcomes of first episode psychosis : An observational and an instrumental variables analysis ', Early Intervention in Psychiatry, vol. 13, no. 4, pp. 841-847 . https://doi.org/10.1111/eip.12676
Aim\ud Duration of untreated psychosis (DUP) is considered a key prognostic variable in psychosis. Yet it is unclear whether a longer DUP causes worse outcomes or whether reported associations have alternative explanations. \ud Methods\ud Data from t
Autor:
Carol Paton, Zachary Fitzgerald, Louise Marston, Patrick Keown, Thomas R. E. Barnes, Rameez Zafar, Khalid Iqbal, Mariwan Husni, Peter M. Haddad, Vineet Singh, Pavel Fridrich, Raj Kumar, Verity C. Leeson, Tim Amos, Hemant Bagalkote, David Osborn
Publikováno v:
Therapeutic Advances in Psychopharmacology
Background:A second antipsychotic is commonly added to clozapine to treat refractory schizophrenia, notwithstanding the limited evidence to support such practice.Methods:The efficacy and adverse effects of this pharmacological strategy were examined